Description

Emerging Technologies

Emerging Technologies The session brings together industrial case studies from practitioners who have delivered innovative solutions to enable the adoption of continuous processing within their companies.

• Commercializing New Chemical Technologies in Flow
  Moiz Diwan, PhD, Director, Head of Enabling Technology Group
  AbbVie  
• Continuous Processing for the Manufacture of Active Pharmaceutical Ingredients
  Martin Johnson, PhD, Sr. Engineering Advisor
  Eli Lilly & Company
• The Use of Kinetic Modelling to Define a Design Space for a Continuous Process
  Peter Shapland, PhD, Scientific Leader, R&D Medicinal Science & Technology
  GSK Stevenage

Moderator(s):

• Malcolm Berry, PhD, Continuous Chemistry Team Manager, MB Chemistry Consulting, Ltd.

Speaker(s):

• Moiz Diwan, PhD, Director, Pharmaceutical Development Research & Development, AbbVie
• Martin Johnson, PhD, Sr. Engineering Advisor, Eli Lilly and Company
• Peter Shapland, PhD, Scientific Leader, R&D Medicinal Science and Technology, GSK Stevenage